Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
9.17
+0.17 (1.89%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Orthofix Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 374 | 600 | 667 | 495 | 411 | 614 | |
Market Cap Growth | -34.18% | -10.03% | 34.66% | 20.62% | -33.09% | -26.12% |
Enterprise Value | 532 | 742 | 793 | 572 | 386 | 557 |
Last Close Price | 9.17 | 15.16 | 17.46 | 13.48 | 20.53 | 31.09 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 14.79 | 26.70 | 22.03 | 22.03 | 21.88 | 35.26 |
PS Ratio | 0.45 | 0.73 | 0.84 | 0.66 | 0.89 | 1.32 |
PB Ratio | 0.87 | 1.33 | 1.33 | 0.83 | 1.22 | 1.82 |
P/TBV Ratio | 2.22 | 3.29 | 3.19 | 1.73 | 1.88 | 2.88 |
P/FCF Ratio | - | - | - | - | - | 889.68 |
P/OCF Ratio | 22.96 | 18.00 | 25.87 | - | - | 33.23 |
PEG Ratio | - | 0.85 | 0.85 | 0.85 | 0.85 | 1.41 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.64 | 0.90 | 0.99 | 0.77 | 0.84 | 1.20 |
EV/EBITDA Ratio | 25.40 | 157.36 | 76.06 | - | 240.26 | 16.91 |
EV/FCF Ratio | - | - | - | - | - | 807.97 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.61 | 0.45 | 0.39 | 0.22 | 0.08 | 0.08 |
Debt / EBITDA Ratio | 9.03 | 16.28 | 10.92 | - | 5.59 | 0.71 |
Debt / FCF Ratio | - | - | - | - | - | 37.33 |
Net Debt / Equity Ratio | 0.37 | 0.27 | 0.22 | 0.17 | -0.07 | -0.18 |
Net Debt / EBITDA Ratio | 7.55 | 25.84 | 10.59 | -2.24 | -14.81 | -1.88 |
Net Debt / FCF Ratio | -5.68 | -95.25 | -12.16 | -0.94 | 0.69 | -89.99 |
Asset Turnover | 0.97 | 0.94 | 0.88 | 1.08 | 0.99 | 0.93 |
Inventory Turnover | 1.34 | 1.36 | 1.17 | 1.39 | 1.35 | 1.37 |
Quick Ratio | 1.53 | 1.28 | 1.29 | 0.98 | 1.60 | 1.57 |
Current Ratio | 2.84 | 2.44 | 2.57 | 2.55 | 3.06 | 2.55 |
Return on Equity (ROE) | -13.91% | -19.34% | -22.87% | -32.36% | -5.86% | -11.06% |
Return on Assets (ROA) | -2.74% | -4.13% | -4.50% | -9.55% | -4.07% | -0.02% |
Return on Invested Capital (ROIC) | -6.45% | -9.72% | -9.98% | -20.88% | -10.37% | -0.05% |
Return on Capital Employed (ROCE) | -5.20% | -8.50% | -9.00% | -13.90% | -8.10% | 0.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -16.52% | -15.36% | -18.88% | -30.55% | -4.81% | -6.25% |
FCF Yield | -7.45% | -0.21% | -1.36% | -21.76% | -8.45% | 0.11% |
Buyback Yield / Dilution | -3.56% | -3.85% | -3.82% | -83.16% | -1.84% | -1.54% |